Pooled risk of cervical cancer increased in women living with HIV
The ESMO Immuno-Oncology Congress 2020, the European platform dedicated to the development and use of immunotherapies for cancer treatment, will be held as a virtual meeting.
Efficacy was evaluated in Study 201 and Study 12-230
It is intended for first-line treatment of blastic plasmacytoid dendritic cell neoplasm, a rare and aggressive type of acute myeloid leukaemia
It received a positive opinion for the treatment of carcinoma of the colon or rectum, breast cancer, non-small cell lung cancer, renal cell carcinoma, epithelial ovarian cancer and carcinoma of the cervix